Journal of Clinical and Translational Science

BackgroundAmid persistent structural barriers and recent national policy changes, early-career physician-scientists face mounting challenges that threaten the sustainability of the biomedical research pipeline in the United States. MethodsWe surveyed early career physician-scientists collecting demographic data, career development support, distribution of clinical and research responsibilities, funding, and perceived career challenges. The survey was distributed by email to the department chairs at 110 institutions in the United States. ResultsA total of 175 surveys were completed. About half 50.8% (n=89) of respondents received a career development award, with 28.9% of respondents reporting limited institutional/departmental support. The most reported challenges were balancing clinical, research, and educational responsibilities (72.5%, n=127); balancing work and family responsibilities (48%, n= 84); limited funding opportunities (48%, n=84); and under-compensation (34.3%, n=60). About 57.7% (n=101) of respondents had considered leaving academic medicine within the next two years, and 83.2% (n=139) indicated a >50% likelihood of doing so within five years. The most frequently cited reasons for attrition were funding challenges (72%, n=126), under-compensation (42.3%, n=74), feeling unhappy or stressed (40.6%, n=71), and burnout (37.7%, n=66). Furthermore, 43.9% (n=76) of respondents reported considering relocation outside the United States for better academic working conditions, and 10.4% (n=18) had already been contacted by institutions abroad. ConclusionEarly-career physician-scientists face substantial structural and financial challenges, with limited institutional support, high rates of burnout, and widespread intent to leave academia. These findings underscore an urgent need for sustained investment, targeted retention strategies, and policy reforms to stabilize and strengthen the physician-scientist workforce in the United States.

Peer reviewers provide a critical service to NIH by evaluating the scientific and technical merit of grant applications. While the tangible rewards for this service are limited, many reviewers feel review service makes them better applicants, improving their grant competitiveness. However, empirical evidence for this claim is limited. This study evaluates relationships between early career peer review service and subsequent application behavior and funding outcomes. Using NIH administrative data, applicants who served as Early Career Reviewers (ECRs) during the 2020 - 2021 council years were compared to a matched group of ECR-eligible applicants who had not served as reviewers (n=1,120 per group). To address non-random selection of ECRs, propensity score matching was used to balance groups on research field, demographics, productivity, career stage, and institutional resources. Outcomes, assessed over a three-year follow-up period, included submission volume, peer review scores, and funding outcomes for R01 and R01-equivalent applications. ECRs submitted more applications, were more likely to have their applications discussed, and were more likely to receive a high review score than matched controls. They were also more likely to receive R01 funding. While peer review scores do not solely determine award outcomes, these findings indicate that peer review service among ECRs is associated with improved grant application outcomes.

Improving diversity in U.S. Alzheimers disease (AD) research is a pressing need. By 2050, Hispanic and Latino Americans will comprise 30% of the population. Hispanics are 1.5 times more likely and Blacks are twice as likely to develop AD compared to Whites, yet both remain vastly underrepresented in clinical trials research. Aging and AD research mentorship of underrepresented STEM undergraduates is designed to promote entry into related professions by students committed to decreasing disparities in AD research participation and clinical care. The NIA-funded MADURA program recruited 93 students from backgrounds historically underrepresented in STEM majors and/or from NIH-defined disadvantaged backgrounds. Trainees were placed in aging/AD research labs and received weekly training and mentorship from faculty research PIs and other types of supervisors (postdoctoral researchers, graduate students, research assistant staff...) Our study examined student ratings of the program and mentor behaviors, using a program-specific survey and the Mentoring Competency Assessment-21 (MCA-21). Trainees were highly satisfied with both mentoring relationships and the overall program. Student rated MCA-21 competency areas were quite high for both P.I.s and other types of research mentors. However, there were striking differences in associations between competencies and relationship and program satisfaction, by mentor type. For PI mentors, no MCA-21 competencies were associated with relationship satisfaction, but five of six competencies were associated with relationship satisfaction for other mentor types. Similarly, no PI mentor competencies were significantly correlated with overall placement satisfaction, but all six competencies were correlated with overall placement satisfaction for other mentor types. The authors discuss the likelihood of differing student expectations of faculty PI versus other types of research mentors, recommendations for assessing role-specific student expectations (including functions primarily possible only for senior faculty PIs), and utilizing nearer-peer plus PI faculty mentors to comprehensively address the gamut of mentee needs.

M.D.-Ph.D. programs in the United States have traditionally followed a "2-n-2" curricular model, with the graduate phase occurring between the pre-clerkship and clerkship portions of medical training. While well established, this format can limit trainee autonomy in shaping their physician-scientist training trajectories. In response, some programs have introduced a "3-n-1" model, allowing students to complete clerkships before beginning Ph.D. training. Our institution implemented multiple flexible curricula in 2017. Understanding why trainees choose one pathway is important as programs consider implementing more adaptable training structures. To investigate these factors, we surveyed M.D.-Ph.D. students at our institution, which offers multiple flexible curricular alternatives, about contributions to their curricular decisions. Responses supported that trainees weigh considerations across medical education, scientific development, and integrated physician-scientist training domains. Although the traditional pathway was a popular option, most students pursued one of the flexible pathways. Our findings suggest that introducing flexibility in the timing of undergraduate medical education and graduate training can support diverse educational, logistical, and personal priorities while maintaining the rigor of physician-scientist training. Offering multiple pathways empowers trainees to design trajectories that best fit their needs. Continued longitudinal studies are needed to assess the long-term impacts of flexible curricula on physician-scientist career outcomes.

Background: Cardiac rehabilitation (CR) is a cost-effective, evidence-based intervention that improves outcomes for patients with heart failure (HF), yet access remains inequitable, particularly among Medicaid enrollees. This study evaluates the state-by-state variability in Medicaid coverage for CR services and examines the implications for health equity in vulnerable populations. Methods: We conducted a cross-sectional policy analysis of all 50 U.S. states to assess Medicaid coverage for outpatient CR services billed under CPT codes 93797 (without ECG monitoring) and 93798 (with ECG monitoring). Publicly available Medicaid documents were reviewed and supplemented with direct communication with state Medicaid agencies. States were categorized into full, partial/inconclusive, or no coverage. Geographic trends were visualized through heat maps and contextualized using state-level Medicaid enrollment data. Results: Marked disparities in CR coverage were identified. Only 41 states reimbursed for CPT 93797, and 43 for CPT 93798. Eight states lacked coverage for either code, predominantly in the South and Mountain West, including Arkansas, Georgia, Louisiana, Mississippi, Nevada, and Utah. States with the highest Medicaid enrollment (e.g., Louisiana, Arkansas) often provided no CR coverage, compounding access barriers for high-risk, low-income populations. Conclusions: The absence of standardized Medicaid coverage for CR contributes to systemic inequities in cardiovascular care, disproportionately impacting disadvantaged communities. Aligning Medicaid policies to ensure universal CR access--particularly through tele-rehabilitation and value-based care models--could reduce hospitalizations, improve survival, and promote health equity across the U.S.

Objectives: Electronic Health Records (EHRs) impose a significant time burden on physicians, often requiring work to be completed outside of scheduled hours. While this burden is well-documented, how it evolves throughout emergency medicine (EM) residency remains poorly understood. This study aimed to quantify EHR usage patterns, analyze the composition of after-shift work, and characterize the development of EHR efficiency across EM training. Methods: We conducted a retrospective cohort study of EM residents (postgraduate year [PGY] 1-4) using 5.5 years of EHR audit log data (2020-2025) at a single academic institution. We analyzed EHR time per new patient encounter, stratified by postgraduate year, and categorized activities into domains such as documentation, chart review, and orders. EHR work was measured both during and after scheduled shifts. Results: The analysis included 144 unique residents and 167,010 new patient encounters across 15,386 shifts. Encounter-attributed EHR time per encounter decreased by 52% from PGY-1 to PGY-4 (median 19.9 to 9.6 minutes, p<0.001), despite an 86% increase in patient volume per shift (median 7 to 13 encounters). This efficiency gain was driven primarily by a 69% reduction in documentation time (9.3 to 2.9 minutes), accompanied by shorter notes. After-shift work (EHR activity after the 9-hour clinical shift) was present in 89.9-94.4% of encounters. At the shift level, combined after-shift EHR time (encounter-attributed plus tracking board) was a median of 64.2 minutes per shift for PGY-1 and 104.2 minutes for PGY-4. Shift-level tracking board activity dominated the after-shift burden and increased with training (median 40.2 to 79.0 minutes per shift from PGY-1 to PGY-4). Conclusions: EM residents achieve substantial gains in on-shift EHR efficiency, with the largest reductions observed in documentation time, accompanied by shorter notes and faster input speed. However, a persistent after-hours workload, dominated by administrative and patient flow tasks, suggests that (at least at this single institution) system-level factors--not just individual skill--may contribute to this pattern. Monitoring these objective EHR metrics may help programs identify struggling learners and evaluate the impact of interventions aimed at improving resident well-being and workflow efficiency.

BackgroundIncomplete dissemination of clinical trial results remains an important challenge for research transparency and evidence synthesis. Although prior studies have quantified the overall extent of non-dissemination, less is known about whether trial characteristics observable at registration are associated with subsequent dissemination within sponsor portfolios. Methods and findingsWe conducted a retrospective cohort study of 17,537 completed interventional clinical trials registered on ClinicalTrials.gov between 2007 and 2024 across the 20 largest global pharmaceutical companies. We developed the Operational Complexity Index (OCI), a composite measure derived from planned enrollment, facility count, and geographic scope, and examined its association with trial dissemination using multivariable logistic regression and time-to-event analyses. Higher OCI was associated with greater odds of dissemination (adjusted odds ratio [aOR] = 2.40, 95% CI 2.23-2.60; p < 0.001), with dissemination increasing from 47% in the lowest OCI decile to 95% in the highest. Higher operational complexity was also associated with earlier dissemination; over a 1,095-day horizon, high-OCI trials were disseminated a mean of 310.88 days earlier than low-OCI trials (RMST difference, 310.88 days; 95% CI 300.59-320.96; p < 0.001). This pattern was observed across sponsors, clinical phases, and therapeutic areas. In predictive analyses using registration-time variables, the structural model achieved a cross- validated AUC of 0.816 and a holdout AUC of 0.814, whereas the full model, including sponsor identity, achieved a cross-validated AUC of 0.858 and a holdout AUC of 0.857. Using benchmark phase-based costing assumptions, the 5,019 non-disseminated trials corresponded to an estimated US$10.94-15.26 billion in sunk research investment. ConclusionsAmong trials conducted by the 20 largest pharmaceutical sponsors, greater operational complexity at registration was associated with a higher likelihood of dissemination and earlier dissemination. These findings suggest that aggregate sponsor-level transparency metrics may mask important heterogeneity within sponsor portfolios. Future work should assess whether registration-time trial characteristics can help identify trial subgroups at higher risk of non-dissemination. AUTHOR SUMMARYO_ST_ABSWhy was this study done?C_ST_ABSO_LIIncomplete dissemination of clinical trial results reduces the completeness of the medical evidence base and the public value of research participation. C_LIO_LIPrevious studies have described overall rates of trial non-dissemination, but less is known about whether dissemination varies systematically across different types of trials within sponsor portfolios. C_LIO_LIWe examined whether trial characteristics available at registration were associated with later dissemination of results among large pharmaceutical sponsors. C_LI What did the researchers do and find?O_LIWe analyzed 17,537 completed interventional clinical trials sponsored by the 20 largest pharmaceutical companies and registered on ClinicalTrials.gov between 2007 and 2024. C_LIO_LIWe developed an Operational Complexity Index (OCI) based on planned enrollment, number of facilities, and geographic scope to measure trial operational scale at registration. C_LIO_LIHigher OCI was associated with a greater likelihood of dissemination and earlier dissemination. Dissemination ranged from 47% in the lowest OCI decile to 95% in the highest. C_LIO_LIThis pattern was observed across sponsor portfolios, clinical phases, and therapeutic areas, with an average within-sponsor dissemination gap of 40 percentage points between lower- and higher-complexity trials. C_LIO_LIIn manual validation of 344 sampled trials, the automated dissemination-classification pipeline achieved 92.1% accuracy. C_LIO_LIUsing benchmark phase-based costing assumptions, the 5,019 non-disseminated trials corresponded to an estimated US$10.9-15.3 billion in sunk research investment. C_LI What do these findings mean?O_LIDissemination was not uniform across trial types within sponsor portfolios; trials with lower operational complexity were less likely to be disseminated than trials with higher operational complexity. C_LIO_LIAggregate sponsor-level transparency measures may therefore miss important differences within portfolios. C_LIO_LIRegistration-time trial characteristics showed predictive signal for non-dissemination, but whether such information could support monitoring strategies would require prospective validation. C_LIO_LIMore complete dissemination of trial results would strengthen the scientific record and improve the public value of clinical research. C_LI

BackgroundHigh workload among healthcare workers has increasingly been correlated with poor patient outcomes, inefficient operational and financial outcomes, and burnout. Despite growing literature exploring causes of attending physician workload, there is limited understanding of trainee-specific measures. ObjectiveWe aimed to characterize elements contributing to trainee workload and perceived challenges and satisfiers to the trainee workday as a foundation for better understanding and measuring trainee work experience. MethodsInternal Medicine and Medicine-Pediatrics residents at an academic medical center were invited to participate in focus groups discussing contributors to inpatient workload and work experience between March and April 2024. A qualitative content analysis identified key metrics of trainee workload and work experience, which were then consolidated into overarching domains. A structured, multi-round rating process ranked the perceived relevance of each metric. ResultsTwenty residents participated across six focus groups. Analysis of focus groups yielded 297 workload metrics across 28 unique domains. Seventeen domains had metrics identified as highly relevant (median 6-7; IQR < 1) including autonomy, communication, disruptions, task switching, documentation, emotional burden, patient factors, professional fulfillment, rounding, teaming, and work-life balance. ConclusionsResident physicians highlighted complex interactions between clinical factors, work design, and psychosocial dynamics that contribute to their sense of workload. This creates opportunities to develop unique measures of workload to understand the trainee experience better. Further studies are needed to capture the generalizability of these findings and the relationship between these workload domains and patient, organizational, and trainee outcomes with the aim of implementing evidence-based work design.

Background: Early clinical exposure and student participation in research are important components of medical training. They may support learning motivation, evidence literacy, and self-directed learning. In many programmes, however, clinical training and research training remain separated. Few studies have explained, within a real teaching team, how learners turn clinical phenomena into researchable questions and how research participation can reshape their clinical understanding. Early Clinical and Research Training (ECART) is a clinical-research integration approach developed by an orthopaedic team at the Second Hospital of Shandong University. Methods: We conducted a theory-informed, interpretivist qualitative single-case study. The case was an orthopaedic clinical-research team at the Second Hospital of Shandong University. Participants included medical undergraduates, academic degree graduate students, professional degree graduate students, clinical teachers, and research platform leads. We used purposive sampling with maximum variation. Data were collected through semi-structured interviews and de-identified teaching documents. Data were analysed using the framework method and were interpreted with a Context-Activity-Mechanism-Outcome (CAMO) logic. Results: The analysis showed that ECART was not simply early entry into the clinic or early entry into the laboratory. It was a team-based learning process centred on real medical problems. Four themes were identified. First, early clinical exposure helped learners make real problems visible and nameable, rather than merely increasing exposure. Second, clinical-research connection followed different pathways. Professional degree graduate students often started from clinical uncertainties in residency training and case management, and moved toward evidence-informed small projects. Academic degree graduate students often started from literature gaps, experimental findings, and mechanistic hypotheses, and then used clinical feedback to calibrate meaning. Third, research training, through literature reading, group meetings, experimental design, data review, and mentor questioning, helped learners move from completing tasks to explaining problems. Fourth, sustained ECART depended on a tiered team ecology formed by clinical teachers, research mentors, research platforms, and senior peers. Based on these findings, we refined the ECART programme theory: real medical problems are translated through explanation, searching, experimentalisation, and feedback-based reinterpretation into research questions that learners can understand, discuss, and test. This process supports problem formation, evidence awareness, mechanistic reasoning, translational judgement, and career clarification. Conclusion: ECART is best understood as a clinical-research integrated learning ecology that emerges from real team practice, rather than as a fixed standardised course. Its educational value lies in a recurring cycle of real problems, research translation, multi-source feedback, and clinical reinterpretation. This framework may inform the design, evaluation, and contextual adaptation of clinical-research integration pathways in medical education.

ABSTRACT OBJECTIVES To examine whether psychological safety and power distance are associated with medical researchers' well-being, and whether these associations operate through team inclusiveness and conflict. DESIGN Cross-sectional survey study. SETTING A biomedical research institute at a major UK university. PARTICIPANTS 133 medical researchers from 17 teams, including 20 principal investigators and 113 team members. MAIN OUTCOME MEASURES Job satisfaction, life satisfaction, intrinsic motivation, and psychological detachment. Mediators were dimensions of team inclusiveness and team conflict. RESULTS Psychological safety had no significant direct associations with job satisfaction, life satisfaction, intrinsic motivation, or psychological detachment, but showed several indirect associations through researchers' team experiences. It was indirectly associated with higher job satisfaction, life satisfaction, and intrinsic motivation primarily through greater integration of differences, inclusion in decision making, or more constructive forms of conflict (bs=.23-.38, ps=.032-<.001).For psychological detachment, psychological safety showed conflicting indirect associations: it had the potential to support detachment through greater integration of differences and lower avoidant conflict (bs=.21-.56, ps=.054-.002), but to undermine detachment through greater inclusion in decision-making (b=-.26, p=.082). Power distance showed a different pattern. Most notably, it was positively associated with psychological detachment (b=.54, p=.062). However, power distance was indirectly associated with lower job satisfaction, life satisfaction, and intrinsic motivation, primarily through reduced integration of differences and greater dominating conflict (bs=-.14 to -.19, ps=.068-.020). CONCLUSIONS Common assumptions about psychological safety and power distance should be revisited. Psychological safety did not show strong direct benefits for researcher well-being, whereas power distance was not uniformly harmful and was positively associated with psychological detachment. A more nuanced understanding of both cultural dimensions is needed in medical research teams.

ImportanceFunding of womens health research has been low, with a narrow focus on what is considered womens health. Understanding which lifespan stages and areas of womens health are funded is essential to determine the breadth of womens health research and identify where gaps in research are concentrated. ObjectiveTo examine which lifespan stages and areas of womens health were more likely to be funded in open Canadian grant competitions. Evidence ReviewPublicly available funded Canadian Institutes of Health Research (CIHR) Project Grant abstracts from 2009 and 2023 were coded for mention of a hormonal transition period (puberty, menstrual cycle, pregnancy/postpartum, perimenopause/menopause), exogenous hormone use (hormonal contraception, fertility treatments, menopause hormone therapy), and/or a female-specific health condition. Abstracts were also coded for Indigenous health and Two Spirit, Lesbian, Gay, Bisexual, Trans, Transgender or Trans Identified, Queer, Intersex, Asexual, Plus (S2/LGBTQIA+) populations. Remaining grant abstracts were grouped by common theme.Abstracts were analyzed for changes in research representation and funding over time and whether funding was lower than expected based on population prevalence or proportion of the lifespan spent in that stage. FindingsNearly 50% of female-specific research focused on cancers (breast, gynecologic) or pregnancy and did not significantly increase in funding or representation over time. Of the funded grant abstracts that focused on pregnancy, ~22% examined outcomes pertaining only to the fetus/offspring, not the birthing parent. Over 15 years, 2.37% of all CIHR abstracts over 15 years were devoted to pregnancy, whereas only 0.24% was devoted to other hormonal life stages (menstrual cycles, menopause). For all hormonal transition stages except pregnancy, the proportion of grants and funding devoted to that stage was lower than expected based on the proportion of the lifespan spent in that stage. Conclusions and RelevanceThese findings reflect the narrow breadth of womens health, which largely focused on cancers (breast, gynecologic) or pregnancy, rather than being distributed across key life course stages that shape womens health. To advance science for all, the heterogeneity and complexity in womens health across the lifespan must be embraced and barriers for womens health research must be removed. Key PointsO_ST_ABSQuestionC_ST_ABSWhich areas and life stages of womens health are most likely to be funded in Canadian open grant competitions, and where are funding gaps concentrated? FindingsNearly half of female-specific grants focused on cancer or pregnancy, with little change over time. Pregnancy dominated hormonal-stage research, often excluding maternal outcomes, while menstrual and menopausal stages were rarely funded. For most life stages, funding was lower than expected based on lifespan representation. MeaningWomens health research funding remains narrowly focused. Broader, life-course-inclusive investment is needed to address critical gaps and advance equitable health science.

Objective: To estimate the adjusted relative risk (RR) of administrative grant disruption faced by first-time and mechanism-first principal investigators (PIs) during the 2025 National Institutes of Health (NIH) grant disruptions. Design: Retrospective cohort study linking NIH RePORTER data to a publicly curated registry of grants disrupted in 2025. Setting: All NIH active research grants in fiscal years 2024 to 2025. Participants: 80,976 active projects: 4,961 disrupted during the wave that peaked in May 2025, 76,015 non-disrupted controls. Main outcome measures: Adjusted RR of disruption by two pre-specified first-time PI constructs: absolute first-time PI (no prior NIH grant) and mechanism-first PI (no prior NIH grant with the same activity code). Modified Poisson regression with institution-clustered standard errors adjusted for project, institutional, and geographic covariates. A pre-specified fiscal year 2024 common-anchor analysis addressed year-of-disruption confounding. Results: Of 4,961 disrupted grants, 237 (4.8%) had an absolute first-time PI and 396 (8.0%) had a mechanism-first PI. After adjustment, absolute first-time PIs faced 77% elevated risk of disruption (RR 1.77, 95% CI 1.34 to 2.32) and mechanism-first PIs faced 57% elevated risk (RR 1.57, 1.16 to 2.11). Under the common-anchor analysis, the absolute first-time effect attenuated to RR 1.22 (0.95 to 1.58); the mechanism-first effect persisted (RR 1.48, 1.07 to 2.06). The elevated risk was concentrated in research-mechanism grants (RR 1.78, 1.26 to 2.52) and was robust across 8 of 9 pre-specified sensitivity analyses. The Track A start-time construct, which asks whether the disrupted project was the PI's debut grant, yielded null estimates (RR 0.98, 0.93 to 1.04), with any effect concentrated entirely in newly started projects. Conclusions: First-time and mechanism-first PIs faced disproportionately elevated risk of disruption during the 2025 NIH wave, concentrated in research-mechanism grants and robust to year-confounding-free identification. The relevant exposure was being early-career at the moment of administrative action, not at project initiation. The findings have direct implications for workforce equity in US biomedical research.

Abstract Objectives Value-Based Health Care (VBHC) increasingly guides health system redesign internationally. Despite the increasing availability of VBHC education, gaps remain between health professionals' conceptual understanding of VBHC and their confidence to implement it in practice. This study assessed perceived learning needs and preferences of healthcare professionals across foundational topics essential to VBHC implementation. Design Cross-sectional online survey study Setting and participants The survey was distributed to the global VBHC community and yielded 518 responses. Most respondents were based in the UK and Ireland (51%) and 65% had more than 10 years of experience in the health sector. Participants represented a variety of professional backgrounds, including clinicians (34%), operational or executive managers and leaders (22%), and life sciences or procurement professionals (13%). Primary and secondary outcome measures Primary outcome measures included self-reported interest and confidence across 15 VBHC domains and the magnitude of the gap between them. Secondary outcomes included perceived implementation challenges and preferred VBHC learning approaches, including prior engagement with VBHC-related learning. Results Respondents identified substantial VBHC implementation challenges, including implementing outcome measurement (62.4%), conflicting priorities (57.7%), and resistance to change (56.8%). Interest in all VBHC domains was high (median >= 80/10), while confidence to implement remained substantially lower across most domains (median <=50/100). The largest interest-confidence gaps were observed for reimbursement mechanisms, costing methodology, and overcoming implementation challenges. Interactive learning approaches, including in-person seminars/workshops (55.2%) and online masterclasses (53.9%) were preferred over self-directed formats. Conclusions This international survey identified consistent gaps between health professionals' interest in VBHC and their confidence to implement key VBHC domains in practice. Addressing these gaps through advanced, targeted and contextual education may support more effective and sustainable VBHC implementation in practice.

BackgroundArtificial intelligence and machine learning (AI/ML) are among the fastest-growing domains in NIH research funding, but whether children have shared equitably in this expansion is unknown. We characterized pediatric representation in NIH AI/ML funding from fiscal years (FY) 2020 to 2024. MethodsNIH grant data were obtained from Research Portfolio Online Reporting Tools Expenditures and Results bulk files for FY2020 to FY2024. AI/ML grants were identified using the NIH Research, Condition, and Disease Categorization "Machine Learning and Artificial Intelligence" category, and pediatric grants using the "Pediatric" category. Subprojects were excluded. Grants were deduplicated within each fiscal year by core project number for trend analyses and across all years retaining the most recent fiscal year for cross-sectional totals. Disease areas were identified by keyword searches of titles and abstracts. ResultsAcross FY2020 to FY2024, 5,624 unique NIH AI/ML grants totaling $3,371 million were identified. Of these, 836 grants (14.9%) were classified as pediatric, representing $401 million (11.9%) of total NIH AI/ML funding. Although this share was consistent with the historically reported overall NIH pediatric funding baseline of approximately 10% to 12%, it remained substantially below the US pediatric population share of approximately 22%. The pediatric share of NIH AI/ML funding declined from 12.3% in FY2020 to 10.8% in FY2024, despite growth in absolute pediatric funding. Indexed to FY2020, pediatric AI/ML funding grew approximately 2.6-fold compared with 3.0-fold growth in the total portfolio. Across disease areas, unadjusted adult/general-to-pediatric funding ratios ranged from 2.0-fold in mental health to 9.8-fold in cancer. ConclusionsPediatric representation in NIH AI/ML funding remained low and declined over time as the overall portfolio expanded. These findings suggest that growth in NIH AI/ML investment has not been matched by proportional gains for pediatric research.

Background: Palliative care services improve quality of life and health outcomes for individuals living with chronic and life-limiting illnesses. Although these services have expanded considerably in urban areas, their availability remains limited in many rural communities. This study aimed to identify key components of integrated palliative care services and examine how these elements are implemented within rural healthcare systems in southern Minnesota. Methods: A qualitative case study using deductive content analysis was conducted. Semi-structured interviews were carried out with healthcare professionals involved in palliative and hospice care serving rural communities in southern Minnesota. Results: Participants identified several essential components of integrated palliative care, including multidisciplinary care teams, continuity of care across healthcare settings, interprofessional collaboration, and early identification of patients who may benefit from palliative care. Existing services in southern Minnesota incorporate several integrated elements, such as coordinated care teams, individualized care plans, nurse-led case management, professional training, and the use of virtual visits for geographically distant patients. However, participants also identified important gaps, including limited availability of palliative care services in rural areas, fragmented continuity of care, challenges in early patient identification, funding and insurance barriers, and the absence of a unified palliative care network. Conclusions: While palliative care services in southern Minnesota demonstrate important strengths, further efforts are required to improve service integration, coordination, and access for rural populations. Strengthening integrated PCSs may help reduce disparities in access to care and improve service delivery for rural patients and their families. These findings may inform the development of integrated palliative care models in rural healthcare systems beyond the study setting.

BackgroundImplementation strategies are dynamic techniques used to apply evidence-based practices (EBPs) to diverse contexts. Despite their importance, context-specific selection and modification of implementation strategies remain underreported, limiting understanding of how to optimize strategy deployment across heterogeneous healthcare settings. We describe a systematic method to document and analyze modifications to implementation strategies using four diverse hospital sites from the Fluoroquinolone Restriction for the Prevention of Clostridioides difficile infection (FIRST) trial as case studies. MethodsFIRST was a multisite fluoroquinolone pre-prescription restriction intervention delivered via the electronic health record. We partnered with multidisciplinary stakeholders at each site to co-design and adapt the intervention using pre-planned implementation strategies. Multiple data sources (interviews, meeting notes, implementation diaries) collected iteratively over two years were analyzed to identify strategy modifications. Strategies were coded using Expert Recommendations for Implementing Change (ERIC) conceptual clusters, and modifications were documented using the Framework for Reporting Adaptations and Modifications to Evidence-Based Implementation Strategies (FRAME-IS). Modified strategies were categorized as planned or unplanned and contextualized via thematic content analysis. ResultsAcross 458 total modifications, the most modified strategies focused on facilitating stakeholder engagement, adapting to local contexts, and using evaluative approaches to improve EBP uptake/sustainment. Planned modifications (n=330, 72%) outnumbered unplanned modifications (n=157, 34%). Rural and community hospitals required more unplanned modifications (average 41 vs. 31 for academic centers), while sites with prior restrictive intervention experience had higher planned-to-unplanned ratios (3.1:1 vs. 1.6:1). Academic hospitals with trainee rotations required ongoing education and higher strategy modifications. All modifications maintained EBP core fidelity. Site-specific patterns organizational characteristics were linked to modification intensity and type, including absorptive capacity, prior experience, relational coordination, rurality, and educational requirements. ConclusionsIntegrating ERIC and FRAME-IS enabled systematic documentation of implementation strategy modifications across diverse settings. Planned:unplanned modification ratios provided novel insights into organizational absorptive capacity and implementation preparedness. Standardized implementation approaches inadequately address critical organizational differences, requiring context-sensitive strategy selection and intensity calibration. This work advances implementation science methodology by demonstrating how systematic modification documentation can inform tailored implementation support. Trial RegistrationClinicalTrials.gov Identifier: NCT03848689

BackgroundHospital visiting-hour policies vary widely across the United States, yet the structural factors shaping this variation remain poorly characterized. ObjectiveThis study investigates how hospital-level financial characteristics, payer mix, and rurality relate to the restrictiveness of inpatient visiting-hour policies, and assesses whether these relationships differ across states with diverse Medicaid expansion statuses. DesignCross-sectional observational analysis of hospital visitor policies in four states (Massachusetts, Wisconsin, Tennessee, and South Carolina) selected based on Medicaid expansion status, population size, and hospital density. ParticipantsA total of 318 acute-care hospitals were included using publicly available data from the Centers for Medicare & Medicaid Services and the National Academy for State Health Policy. Main MeasuresThe primary outcome was total daily visiting hours in general inpatient wards. Predictors included volume/capacity, patient mix, financial performance/efficiency, geography and organizational structure. Key ResultsHospital-level characteristics including higher Medicaid payer mix, stronger financial margins, greater inpatient occupancy, and larger size were associated with shorter visiting hours in unadjusted analyses. Commercial payer mix and rurality predicted longer hours. Mean visiting duration was 14.1 hours/day (SD = 5.07; range 0-24), with Massachusetts having the shortest on average across states (10.5 hours/day) and Wisconsin the longest (16.3 hours/day). Medicaid payer mix was the only predictor associated with visiting-hour restrictiveness after multiple-testing correction. Each 10-percentage-point increase in Medicaid payer mix was associated with an approximately 11.3% decrease (p = 0.002) in visiting hours. Within-state variation exceeded the differences between-states. ConclusionsVisitation hours vary considerably, with correlations around rurality of the community served, size of the hospital, and the number of patients on Medicaid. Medicaid payer mix emerged as the most consistent predictor of restrictiveness after adjustment. Hospitals can use these findings to evaluate visitation practices to balance patient-centered care with operational demands.

BackgroundPersons experiencing homelessness (PEH) have a 2-3-fold greater risk for cardiovascular disease (CVD) mortality compared with domiciled counterparts. Evidence has repeatedly shown elevated chronic disease burden, reduced access to many types of care, and lower utilization of medication to control CVD risk factors in clinical settings dedicated to providing health care to PEH. There are federally funded health clinics targeting barriers to access for patient populations experiencing homelessness in place. These clinics are frequently overwhelmed and limited by their scope to primary care despite well documented burdens of co- and tri-morbid conditions. There is scarce evidence on differences between access, quality, and experiences of care delivered relative to other safety-net models. MethodThe 2022 Health Center Patient Survey (HCPS) was collected on behalf of the Health Resources and Services Administration (HRSA). The HCPS is a nationally representative, three-staged, sample-based survey collected via 1:1 interview with clinic patients. The survey assessed sociodemographics, health conditions and behaviors, access to and utilization of care, and patients experiences with comprehensive services they received at HRSA-funded Federally Qualified Health Centers (FQHCs), including community health centers (CHC), healthcare for the homeless (HCH) clinics, and public housing primary care (PHPC) clinics. One hundred and three unique awardees and 318 health center sites were recruited, and 4,414 patient interviews were completed. Investigators analyzed patient characteristics and multiple survey items related to AHAs Essential 8 metrics for differences between HCH and CHC patient responses. ResultsHCH clinics had fewer elderly patients ([~]7%) than CHCs ([~]17%). Reported 7-day physical activity measures, average sleep below 7 hours per day, and Lifetime smoking (>100 cigarettes; OR=4.2, p<0.001) were all greatest among HCH patients. Fewer HCH patients reported ever having or recent lipid tests (both p<0.001). HCH patients were more likely to report hypertension (p=0.003) but less likely to report receiving nutrition advice (all p<0.05). HCH patients were less likely to be taking medication even if it was prescribed (p<0.001). Adjustments for differences in age or CVD history were able to explain some observed differences but increased the magnitude of other disparities. ConclusionsCVD burden differs across the various HRSA funding mechanisms for clinics, as do demographics and multiple metrics of health behaviors and biomarkers of cardiovascular health. Greater disease burden in HCH patients is likely compounded by increased risk factors and underperformance in providing health education interventions. Clinical PerspectiveO_ST_ABSWhat Is New?C_ST_ABSO_LIPatients accessing Health Care for the Homeless clinics demonstrate unique cardiovascular risk profiles characterized by higher rates of inadequate sleep, smoking history, and pre-diabetes compared to Community Health Center patients, even after adjusting for sociodemographic factors. C_LI What Are the Clinical Implications?O_LITraditional cardiovascular disease risk assessment tools and prevention strategies may need to be recalibrated for homeless populations, as standard clinical metrics and screening approaches may not fully capture the complex interplay of behavioral, environmental, and social exposures affecting this vulnerable group. C_LI Research PerspectiveO_ST_ABSWhat New Question Does This Study Raise?C_ST_ABSO_LIHow do structural inequities and comorbid conditions resulting in and from homelessness impact health in ways that may not be captured by conventional risk assessment tools? C_LI What Question Should be Addressed Next?O_LIWhat modifications to evidence-based cardiovascular interventions are needed to effectively serve people experiencing homelessness, and how can these interventions be integrated into Health Care for the Homeless clinics and other FQHCs? C_LI

Background and ObjectivesPatient portals have become essential infrastructure for healthcare delivery following the 21st Century Cures Act, yet adoption remains inequitable. Understanding demographic and geographic determinants of portal activation is critical for addressing digital health disparities, particularly among neurology patients who face unique access barriers. We examined the demographic, geographic, and neighborhood-level factors associated with patient portal activation among neurology patients at multiple geographic scales in the Washington, DC metropolitan area. MethodsWe conducted a retrospective cohort study of 72,417 adult neurology patients seen at two academic medical centers sharing an electronic health record in Washington, DC (February 2021-February 2026). We examined portal activation using multivariable logistic regression and geographic analysis at four nested scales: the metropolitan catchment area, DCs eight wards, individual census tracts (via geocoded patient addresses), and individual DC residents. ResultsPortal activation was 64.7% overall. Activation varied by race/ethnicity (Non-Hispanic White 76.1%, Non-Hispanic Black 57.0%, Non-Hispanic Asian 57.6%, Hispanic 55.0%) and geography (DC Ward 2: 82.0% vs. Ward 7: 48.0%). Ward-level educational attainment (r = 0.948), broadband access (r = 0.889), and income (r = 0.811) were strongly correlated with activation. Within individual wards, Non-Hispanic White patients activated at 84-91% while Non-Hispanic Black patients activated at 48-64%, demonstrating that neighborhood resources alone do not explain disparities. DiscussionPatient portal activation is shaped by demographic, socioeconomic, and geographic factors operating at multiple levels. Persistent within-ward racial disparities indicate that geographically targeted interventions must be paired with culturally tailored approaches to achieve digital health equity.

Background Open health data repositories receive billions in public funding, yet no systematic framework exists to evaluate their downstream scholarly impact, the composition of the research communities they cultivate, or the breadth of disciplines they reach. We introduce a two-degree citation methodology to quantify knowledge diffusion from open data, normalized by funding, and apply it to four major health data repositories. Methods Using the OpenAlex bibliometric database (January-February 2026), we identified all first-degree citing publications (n = 30,049) and their second-degree citing publications (n = 485,396), defined as papers citing those first-degree publications, for MIMIC (versions I-IV; retrospective EHR data; $14.4M), UK Biobank (prospective cohort with genomics; $525.5M), OpenSAFELY (federated EHR platform; $53.7M), and All of Us (prospective national cohort with biobanking and community engagement; $2,160M). We extracted author demographics (gender via Genderize.io, institutional country income via World Bank 2024 classifications) and research topics. Chi-square tests with odds ratios assessed demographic differences across repositories. Results Funding-normalized first-degree papers per $1M ranged from 689 (MIMIC) to 1 (All of Us), though these figures reflect total program investment, which included community engagement and biobanking for prospective cohorts in addition to data-curation costs. The citation amplification ratio was consistent across these four repositories (9.3-11.5x). Author demographics differed significantly (p < 0.001): LMIC authorship ranged from 41.8% (MIMIC) to 4.3% (All of Us), while female authorship showed the opposite pattern, lowest for MIMIC (31.8%) and highest for All of Us (43.2%). Female authors were consistently underrepresented in senior (last-author) compared with first-author positions across all repositories. Differences in scope, design, and what funding covers limit direct comparisons. Conclusions Open health data generates a consistent ~10x indirect citation amplification beyond its direct users, a ratio that held across repositories spanning over two orders of magnitude in funding. The large differences in funding-normalized output partly reflect structural differences between retrospective databases and prospective cohorts. Low-cost access combined with intentional community building attracted globally diverse research communities with LMIC investigators in intellectual leadership positions, while a persistent gender gap in senior authorship across all repositories reflects disciplinary and structural inequities that data access policies alone cannot address. Future evaluations of open data investments should examine who is producing research, from where, in what positions, and whether their participation translates into locally relevant knowledge production.